Cell Growth & Differentiation, Vol 8, Issue 4 381-392, Copyright © 1997 by American Association of Cancer Research

ARTICLES

Protein kinase C-beta 2 inhibits cycling and decreases c-myc-induced apoptosis in small cell lung cancer cells

LF Barr, SE Campbell and SB Baylin
Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland 21205, USA.

The overexpression of c-myc frequently accompanies the relapse of small cell lung cancer (SCLC) cells and contributes to the poor prognosis of this tumor. In this study, we confirm that transfected c-myc results in decreased homotypic cell aggregation and increased proliferative capacity of SCLC cells when nutrient conditions are adequate. We also find that c-myc contributes to apoptosis when cells are nutrient depleted, and flow cytometry suggests that this enhanced apoptosis is associated with a failure to halt cell cycling, consistent with the experience in other cell types. We previously found that protein kinase C-beta (PKC-beta) expression in NCI H209 (209) SCLC cells increases markedly with c-myc transfection (L. F. Barr et al., Cancer Res., 51: 5514-5519, 1991), and we hypothesized that PKC-beta may mediate some of the effects of c-myc in these cells. We test this hypothesis by transfection of rat PKC-beta 1 and bovine PKC-beta 2 isoforms into 209 cells before and after transfection with c-myc. PKC-beta 1 transfection has no effect on these cells. However, PKC-beta 2 expression has distinct phenotypic consequences. In the parental cells, PKC-beta 2 expression results in increased homotypic cell aggregation and a prolonged doubling time. Furthermore, PKC-beta 2 expression increases the fraction of these cells in G0-G1. In the cells which express a transfected c-myc gene, PKC-beta 2 expression improves the survival of cells in low serum by decreasing myc-induced apoptosis. This effect was associated with, and may be mediated by, a selection for cells in the G0-G1 fraction. We postulate that transfection of c-myc into SCLC cells may select for those expressing the PKC-beta 2 gene because this signal transduction event protects against myc-induced apoptosis.

This article has been cited by other articles:

				Y. Oh, R. S. Herbst, H. Burris, A. Cleverly, L. Musib, M. Lahn, and G. Bepler Enzastaurin, an Oral Serine/Threonine Kinase Inhibitor, As Second- or Third-Line Therapy of Non-Small-Cell Lung Cancer J. Clin. Oncol., March 1, 2008; 26(7): 1135 - 1141. [Abstract] [Full Text] [PDF]

				R. S. Herbst, Y. Oh, A. Wagle, and M. Lahn Enzastaurin, a Protein Kinase C{beta} Selective Inhibitor, and Its Potential Application as an Anticancer Agent in Lung Cancer Clin. Cancer Res., August 1, 2007; 13(15): 4641s - 4646s. [Abstract] [Full Text] [PDF]

				A. Hurbin, J.-L. Coll, L. Dubrez-Daloz, B. Mari, P. Auberger, C. Brambilla, and M.-C. Favrot Cooperation of Amphiregulin and Insulin-like Growth Factor-1 Inhibits Bax- and Bad-mediated Apoptosis via a Protein Kinase C-dependent Pathway in Non-small Cell Lung Cancer Cells J. Biol. Chem., May 20, 2005; 280(20): 19757 - 19767. [Abstract] [Full Text] [PDF]

				T. B. Deb, C. M. Coticchia, and R. B. Dickson Calmodulin-mediated Activation of Akt Regulates Survival of c-Myc-overexpressing Mouse Mammary Carcinoma Cells J. Biol. Chem., September 10, 2004; 279(37): 38903 - 38911. [Abstract] [Full Text] [PDF]

				G. N. Pandey, Y. Dwivedi, H. S. Rizavi, X. Ren, and R. R. Conley Decreased Catalytic Activity and Expression of Protein Kinase C Isozymes in Teenage Suicide Victims: A Postmortem Brain Study Arch Gen Psychiatry, July 1, 2004; 61(7): 685 - 693. [Abstract] [Full Text] [PDF]

				M. Asghar, T. Hussain, and M. F. Lokhandwala Overexpression of PKC-{beta}I and -{delta} contributes to higher PKC activity in the proximal tubules of old Fischer 344 rats Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1100 - F1107. [Abstract] [Full Text]

				C. Moon, Y. Oh, and J. A. Roth Current Status of Gene Therapy for Lung Cancer and Head and Neck Cancer Clin. Cancer Res., November 1, 2003; 9(14): 5055 - 5067. [Abstract] [Full Text] [PDF]

				L. Ding, H. Wang, W. Lang, and L. Xiao Protein Kinase C-epsilon Promotes Survival of Lung Cancer Cells by Suppressing Apoptosis through Dysregulation of the Mitochondrial Caspase Pathway J. Biol. Chem., September 13, 2002; 277(38): 35305 - 35313. [Abstract] [Full Text] [PDF]

				E. C. Dempsey, A. C. Newton, D. Mochly-Rosen, A. P. Fields, M. E. Reyland, P. A. Insel, and R. O. Messing Protein kinase C isozymes and the regulation of diverse cell responses Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L429 - L438. [Abstract] [Full Text] [PDF]

				L. A. Davidson, R. E. Brown, W.-C. L. Chang, J. S. Morris, N. Wang, R. J. Carroll, N. D. Turner, J. R. Lupton, and R. S. Chapkin Morphodensitometric analysis of protein kinase C {beta}II expression in rat colon: modulation by diet and relation to in situ cell proliferation and apoptosis Carcinogenesis, August 1, 2000; 21(8): 1513 - 1519. [Abstract] [Full Text] [PDF]

				L. F. Barr, S. E. Campbell, G. B. Diette, E. W. Gabrielson, S. Kim, H. Shim, and C. V. Dang c-Myc Suppresses the Tumorigenicity of Lung Cancer Cells and Down-Regulates Vascular Endothelial Growth Factor Expression Cancer Res., January 1, 2000; 60(1): 143 - 149. [Abstract] [Full Text]

				Y. Tan, H. Ruan, M. R. Demeter, and M. J. Comb p90RSK Blocks Bad-mediated Cell Death via a Protein Kinase C-dependent Pathway J. Biol. Chem., December 3, 1999; 274(49): 34859 - 34867. [Abstract] [Full Text] [PDF]

				C. Ruiz-Ruiz, G. Robledo, J. Font, M. Izquierdo, and A. Lopez-Rivas Protein Kinase C Inhibits CD95 (Fas/APO-1)-Mediated Apoptosis by at Least Two Different Mechanisms in Jurkat T Cells J. Immunol., November 1, 1999; 163(9): 4737 - 4746. [Abstract] [Full Text] [PDF]

				L. Paolucci and E. Rozengurt Protein Kinase D in Small Cell Lung Cancer Cells: Rapid Activation through Protein Kinase C Cancer Res., February 1, 1999; 59(3): 572 - 577. [Abstract] [Full Text] [PDF]